Cholinergic hyperinnernation in early life regulates long-term airway reactivity
生命早期的胆碱能过度调节调节长期气道反应性
基本信息
- 批准号:9386170
- 负责人:
- 金额:$ 17.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-14 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineActinsAdultAdult asthmaAdvisory CommitteesAffectAgeAgonistAllergensAnimal Disease ModelsAnimal ModelAnti-CholinergicsAreaAsthmaBiologyBirthBronchodilator AgentsCell Culture TechniquesCellular MechanotransductionChildChildhoodChildhood AsthmaChronicChronic Obstructive Airway DiseaseClinicalCommunitiesDevelopmentDevelopment PlansDiseaseDisease ProgressionEconomic BurdenEnvironmental ExposureEvaluationEventExposure toFamilyFosteringFoundationsFunctional disorderFundingGene ExpressionGenesGoalsHealthHumanInfantKnockout MiceLeadLifeLightLungLung diseasesMaintenanceMediatingMentorsMethodsMicroarray AnalysisModelingMolecularMolecular BiologyMorbidity - disease rateMusNatureNebulizerNerveObstructive Lung DiseasesPathogenicityPathway interactionsPatientsPharmaceutical PreparationsPharmacologic SubstancePhysiciansPlayPrecision therapeuticsPredispositionPreventionRecoveryRegulationResearchRespiratory physiologyRiskRoleSalineScientistSignal PathwaySignal TransductionSliceSmall Interfering RNASmooth MuscleStructureStudy SkillsTestingTherapeuticTimeTrainingTraining ProgramsUnited StatesUnited States National Institutes of HealthUp-RegulationWorkage groupage relatedairway hyperresponsivenessanalogasthmaticcareercareer developmentcholinergicenvironmental changehealth economicsin vivoinfancyinsightknock-downlung developmentmechanotransductionmethacholinemouse modelmuscle physiologynerve supplyneuroregulationnew therapeutic targetoverexpressionpollutantpostnatalpreventpuprelating to nervous systemrespiratoryrespiratory smooth musclerespiratory virustiotropiumtreatment strategy
项目摘要
Project Summary:
Asthma is a chronic respiratory disease affecting more than 25 million people including 7 million children
in the United States and imposing a substantial health and economic burden on patients, their families and the
communities. Although asthma may affect all age groups, it most often starts during childhood. Clinical
observations have revealed early life environmental insults are associated with increased risk of chronic airway
obstructive diseases including asthma. In addition, there is increasing recognition that lung function throughout
life is profoundly impacted by respiratory events that occur during the time period of postnatal lung development.
These findings highlight the significance of more fully understanding age-related specific airway adaptive
changes from environmental exposures in early life.
Our work in progress with an early life mouse asthma model has revealed a key role of neural
dysregulation of airway smooth muscle (ASM) in the maintenance of airway hyperreactivity (AHR). We found
early life allergen exposure induced a unique upregulation of ASM contractility via cholinergic hyperinnervation.
This contractile plasticity of ASM in the time window of postnatal airway development played a key role in
retaining long term AHR. In contrast, alteration in neural regulation and subsequent long term enhancement of
airway contractility was not seen in a murine model of adult asthma. Moreover, microarray analysis of ASM
revealed gene expression of CD38 and -actinin1 (ACTN1) was selectively upregulated in P21 ASM following
allergen exposure. These genes have established role in the contractile regulation of ASM. We therefore
hypothesize that cholinergic stimulation during postnatal development aberrantly activates Ca2+ and ACTN1-
mediated pathways in ASM, which in turn causes persistent AHR. We propose to test this hypothesis by 1)
identifying the critical time window during which ASM is vulnerable to the aberrant cholinergic regulation; 2)
investigating two potential mechanisms underlying cholinergic stimulation induced ASM hypercontractility, ie
CD38 mediated Ca2+ signaling pathway and ACTN1 mediated intracellular mechanotransduction; and 3)
evaluating the efficacy of anti-cholinergic medication in the prevention of persistent AHR following early life
allergen exposure.
With the guidance of my mentors, Drs. Xingbin Ai and Bruce Levy, we have developed a five-year training
program that includes both tailored didactic and technical training to develop additional skills for study of the
regulation of ASM in health and disease. Importantly, this project will be overseen by a scientific career advisory
committee with expertise related to key areas of this proposal, including ASM physiology, molecular and
developmental lung biology and animal disease models. The proposed career development plan will establish
scientific foundations and provide the additional training necessary to achieve my ultimate goal of becoming an
independent, NIH-funded physician-scientist studying pulmonary smooth muscle biology and dysregulation in
lung diseases.
项目摘要:
哮喘是一种慢性呼吸道疾病,影响超过2500万人,包括700万儿童
在美国,对患者,家人和
社区。
观察结果表明,早期生活环境的侮辱与慢性空气气道的风险增加有关
梗阻性疾病还包括哮喘。
生命受到发生产后肺发育时期的呼吸事件的深远影响。
这些发现突出了一些更完全贾斯和年龄相关的特定气道自适应
早期环境暴露的变化。
我们通过早期生活鼠标模型正在进行的工作揭示了神经的关键作用
气道肌肉(ASM)的失调在维持气道高反应性(AHR)中
早期生命过敏原暴露通过胆碱能过度保育对ASM收缩性的独特上调。
在产后气道开发时间窗口中,ASM的收缩塑料在
保留长期AHR。
此外,在成人哮喘的鼠模型中没有看到气道收缩力。
在P21 ASM中选择性上调CD38和-actinin1(ACTN1)的启示基因表达
因此,这些基因在ASM的收缩调节中确立了作用
假设在产后发育期间硫蛋白能刺激异常激活Ca2+和Actn1-
ASM中的介导途径,这又导致持久性AHR。
确定ASM容易受到异常胆碱能调节的关键时间窗口;
研究了胆碱能刺激引起的ASM超额合同的两种潜在机制,即
CD38介导的Ca2+信号通路和ACTN1介导的细胞内机械转换;
评估抗胆碱能药物在预防早期持续性AHR方面的疗效
过敏原暴露。
在我的导师的指导下,Drs。
计划包括量身定制的教学培训和技术培训,以开发额外的技能来研究
对健康和疾病的监管。
委员会具有与本提案的关键领域有关的专业知识。
发育性肺肺生物学和动物疾病模型。
科学基础并提供额外的培训,以实现我的最终目标
独立的NIH资助的医师科学家研究肺平滑肌生物学和在
肺部疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yan Bai其他文献
Yan Bai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yan Bai', 18)}}的其他基金
Cholinergic hyperinnernation in early life regulates long-term airway reactivity
生命早期的胆碱能过度调节调节长期气道反应性
- 批准号:
10217685 - 财政年份:2017
- 资助金额:
$ 17.22万 - 项目类别:
相似国自然基金
肌动蛋白成核促进因子SHRC的结构和分子机制的研究
- 批准号:32301034
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
染色质重塑因子肌动蛋白样6A在视网膜变性中的作用机制及干预研究
- 批准号:82371081
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肌动蛋白结合蛋白Xirp2介导基质刚度诱导心肌细胞肥大的力学生物学机制
- 批准号:12372314
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
肌动蛋白结合蛋白ANLN在胆汁淤积性肝损伤后肝再生过程中的作用及机制研究
- 批准号:82370648
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
WDR1介导的肌动蛋白解聚动态平衡在小脑浦肯野细胞衰老性焦亡中的作用研究
- 批准号:32371053
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Memory and ProBDNF Processing in the Aged Mouse Hippocampus
老年小鼠海马体的记忆和 ProBDNF 处理
- 批准号:
8113539 - 财政年份:2011
- 资助金额:
$ 17.22万 - 项目类别:
Memory and ProBDNF Processing in the Aged Mouse Hippocampus
老年小鼠海马体的记忆和 ProBDNF 处理
- 批准号:
8277213 - 财政年份:2011
- 资助金额:
$ 17.22万 - 项目类别:
Restoration of Fecal Continence in Aging IAS
老年 IAS 患者大便失禁的恢复
- 批准号:
7901968 - 财政年份:2009
- 资助金额:
$ 17.22万 - 项目类别:
Restoration of Fecal Continence in Aging IAS
老年 IAS 患者大便失禁的恢复
- 批准号:
8214650 - 财政年份:2008
- 资助金额:
$ 17.22万 - 项目类别:
Restoration of Fecal Continence in Aging IAS
老年 IAS 患者大便失禁的恢复
- 批准号:
8368311 - 财政年份:2008
- 资助金额:
$ 17.22万 - 项目类别: